Infection and Immunity · 2005 · 98 citations · 41 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationMolecular VirologyVaccinologyDna VaccinesNucleic Acid VaccinesRecombinant Protein VaccinesVaccinationVector-based VaccinesZoonotic Disease VaccinesAdenoviral Vaccine VectorsAdenovirus VaccinesAdenovirus VectorsCross-protective ImmunityDna Vector VaccinesLeptospirosis VaccinesPlasmid Dna VectorsPlasmid Vaccine Vectors
The use of DNA constructs encoding leptospiral proteins is a promising new approach for vaccination against leptospirosis. In previous work we determined that immunization with hemolysis-associated protein 1 (Hap1) (LipL32) expressed by adenovirus induced significant protection against a virulent Leptospira challenge in gerbils. To avoid the use of the adenovirus vector, we checked for clinical protection against lethal challenge by DNA vaccination. A DNA vaccine expressing Hap1 was designed to enhance the direct gene transfer of this protein into gerbils. A challenge was performed 3 weeks after the last immunization with a virulent strain of serovar canicola. Our results show that the cross-protective effect with pathogenic strains of Leptospira, shared by Hap1, could be mediated by the DNA plasmid vector. This finding should facilitate the design and development of a new generation of vaccines against bacteria, particularly Leptospira interrogans sensu lato.
41
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Haider Raza, Annie John, Abderrahim Nemmar · Cellular Physiology and Biochemistry · 2013 · 47.3K citations · Full text
Urban epidemic of severe leptospirosis in Brazil
Albert I. Ko, Mitermayer Galvão dos Reis, Cibele Maria Ribeiro Dourado et al. · The Lancet · 1999 · 765 citations